Multiple inflammatory pathways are involved in the development and progression of cognitive deficits in APPswe/PS1dE9 mice (Q48692630)

14 February 2018

retracted paper

2 references

Dataset for "Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine"

Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine

title

Multiple inflammatory pathways are involved in the development and progression of cognitive deficits in APPswe/PS1dE9 mice (English)

1 reference

14 February 2018

author name string

Wei Zhang

1 reference

14 February 2018

Miao Bai

1 reference

14 February 2018

Ye Xi

1 reference

14 February 2018

Jian Hao

1 reference

14 February 2018

Zhuo Zhang

1 reference

14 February 2018

Changjun Su

1 reference

14 February 2018

Gesheng Lei

1 reference

14 February 2018

Jianting Miao

1 reference

14 February 2018

Zhuyi Li

1 reference

14 February 2018

publication date

25 January 2012

1 reference

14 February 2018

published in

Neurobiology of Aging

1 reference

14 February 2018

volume

1 reference

14 February 2018

issue

1 reference

14 February 2018

page(s)

2661-2677

1 reference

14 February 2018

S14G-Humanin ameliorates Abeta25-35-induced behavioral deficits by reducing neuroinflammatory responses and apoptosis in mice

cites work

1 reference

3 January 2024

https://opencitations.net/index/api/v1/citations/10.1016/J.NPEP.2008.08.004

No effect of one-year treatment with indomethacin on Alzheimer's disease progression: a randomized controlled trial

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROBIOLAGING.2011.12.023

Common mechanisms of amyloid oligomer pathogenesis in degenerative disease

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROBIOLAGING.2011.12.023

Long-term efficacy and safety of celecoxib in Alzheimer's disease

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROBIOLAGING.2011.12.023

Tumor necrosis factor-alpha, interleukin-1beta, and interferon-gamma stimulate gamma-secretase-mediated cleavage of amyloid precursor protein through a JNK-dependent MAPK pathway

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROBIOLAGING.2011.12.023

Minocycline reduces microglial activation and improves behavioral deficits in a transgenic model of cerebral microvascular amyloid.

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROBIOLAGING.2011.12.023

Effect of Anti-inflammatory Medications on Neuropathological Findings in Alzheimer Disease

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROBIOLAGING.2011.12.023

Neuroinflammation in Alzheimer's disease: mechanisms, pathologic consequences, and potential for therapeutic manipulation

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROBIOLAGING.2011.12.023

Characterization of amyloid deposition in the APPswe/PS1dE9 mouse model of Alzheimer disease

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROBIOLAGING.2011.12.023

Astrocytes are important mediators of Aβ-induced neurotoxicity and tau phosphorylation in primary culture.

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROBIOLAGING.2011.12.023

Non-steroidal anti-inflammatory drugs (NSAIDs) in Alzheimer's disease: old and new mechanisms of action

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROBIOLAGING.2011.12.023

Risk of Alzheimer's disease and duration of NSAID use.

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROBIOLAGING.2011.12.023

Interleukin-6 inhibits long-term potentiation in rat hippocampal slices

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROBIOLAGING.2011.12.023

Focal glial activation coincides with increased BACE1 activation and precedes amyloid plaque deposition in APP[V717I] transgenic mice

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROBIOLAGING.2011.12.023

Early correlation of microglial activation with enhanced tumor necrosis factor-alpha and monocyte chemoattractant protein-1 expression specifically within the entorhinal cortex of triple transgenic Alzheimer's disease mice

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROBIOLAGING.2011.12.023

Are NSAIDs useful to treat Alzheimer's disease or mild cognitive impairment?

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROBIOLAGING.2011.12.023

Anti-inflammatory drug therapy alters beta-amyloid processing and deposition in an animal model of Alzheimer's disease.

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROBIOLAGING.2011.12.023

Neuroinflammation, oxidative stress and the pathogenesis of Alzheimer's disease

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROBIOLAGING.2011.12.023

Cyclooxygenase (COX)-2 and COX-1 Potentiate β-Amyloid Peptide Generation through Mechanisms That Involve γ-Secretase Activity

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROBIOLAGING.2011.12.023

The contribution of activated astrocytes to Aβ production: implications for Alzheimer's disease pathogenesis

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROBIOLAGING.2011.12.023

The novel squamosamide derivative FLZ enhances BDNF/TrkB/CREB signaling and inhibits neuronal apoptosis in APP/PS1 mice

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROBIOLAGING.2011.12.023

Aspirin and non-steroidal anti-inflammatory drugs inhibit amyloid-beta aggregation

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROBIOLAGING.2011.12.023

Rofecoxib: no effect on Alzheimer's disease in a 1-year, randomized, blinded, controlled study

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROBIOLAGING.2011.12.023

Episodic-like memory deficits in the APPswe/PS1dE9 mouse model of Alzheimer's disease: relationships to beta-amyloid deposition and neurotransmitter abnormalities

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROBIOLAGING.2011.12.023

Prostaglandin E2-induced synaptic plasticity in neocortical networks of organotypic slice cultures.

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROBIOLAGING.2011.12.023

Reactive glia not only associates with plaques but also parallels tangles in Alzheimer's disease

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROBIOLAGING.2011.12.023

Reduced incidence of AD with NSAID but not H2 receptor antagonists: the Cache County Study

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROBIOLAGING.2011.12.023

The inhibitory effect of interleukin-1beta on long-term potentiation is coupled with increased activity of stress-activated protein kinases

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROBIOLAGING.2011.12.023

Lipopolysaccharide-induced-neuroinflammation increases intracellular accumulation of amyloid precursor protein and amyloid beta peptide in APPswe transgenic mice

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROBIOLAGING.2011.12.023

Interferon-gamma and tumor necrosis factor-alpha regulate amyloid-beta plaque deposition and beta-secretase expression in Swedish mutant APP transgenic mice

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROBIOLAGING.2011.12.023

Expression of macrophage colony-stimulating factor receptor is increased in the AbetaPP(V717F) transgenic mouse model of Alzheimer's disease

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROBIOLAGING.2011.12.023

Microglia, amyloid, and cognition in Alzheimer's disease: An [11C](R)PK11195-PET and [11C]PIB-PET study

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROBIOLAGING.2011.12.023

Prostaglandin E2 stimulates the production of amyloid-beta peptides through internalization of the EP4 receptor.

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROBIOLAGING.2011.12.023

A subset of NSAIDs lower amyloidogenic Abeta42 independently of cyclooxygenase activity

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROBIOLAGING.2011.12.023

Tumor necrosis factor alters synaptic transmission in rat hippocampal slices

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROBIOLAGING.2011.12.023

Evidence that increased hippocampal expression of the cytokine interleukin-1 beta is a common trigger for age- and stress-induced impairments in long-term potentiation.

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROBIOLAGING.2011.12.023

Reducing cerebral microvascular amyloid-beta protein deposition diminishes regional neuroinflammation in vasculotropic mutant amyloid precursor protein transgenic mice.

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROBIOLAGING.2011.12.023

Naproxen and celecoxib do not prevent AD in early results from a randomized controlled trial

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROBIOLAGING.2011.12.023

The inhibitory effects of interleukin-6 on synaptic plasticity in the rat hippocampus are associated with an inhibition of mitogen-activated protein kinase ERK

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROBIOLAGING.2011.12.023

CHF5074, a novel gamma-secretase modulator, restores hippocampal neurogenesis potential and reverses contextual memory deficit in a transgenic mouse model of Alzheimer's disease

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROBIOLAGING.2011.12.023

Interactions between APP secretases and inflammatory mediators

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROBIOLAGING.2011.12.023

Neuroinflammatory processes in Alzheimer's disease

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROBIOLAGING.2011.12.023

Role of aggregation conditions in structure, stability, and toxicity of intermediates in the Abeta fibril formation pathway

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROBIOLAGING.2011.12.023

Increase in the density of resting microglia precedes neuritic plaque formation and microglial activation in a transgenic model of Alzheimer's disease

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROBIOLAGING.2011.12.023

Nonsteroidal Antiinflammatory Drugs and the Risk of Alzheimer's Disease

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROBIOLAGING.2011.12.023

A double-blind, placebo-controlled trial of diclofenac/misoprostol in Alzheimer's disease.

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROBIOLAGING.2011.12.023

Intracellular Aβ-oligomers and early inflammation in a model of Alzheimer's disease

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROBIOLAGING.2011.12.023

Alzheimer's disease: the amyloid cascade hypothesis

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROBIOLAGING.2011.12.023

NSAIDs: How they Work and their Prospects as Therapeutics in Alzheimer's Disease

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROBIOLAGING.2011.12.023

Assessment of neuroinflammation and microglial activation in Alzheimer's disease with radiolabelled PK11195 and single photon emission computed tomography. A pilot study

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROBIOLAGING.2011.12.023

Involvement of prostaglandin E2 in production of amyloid-beta peptides both in vitro and in vivo

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROBIOLAGING.2011.12.023

Soluble Aβ levels correlate with cognitive deficits in the 12-month-old APPswe/PS1dE9 mouse model of Alzheimer's disease

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROBIOLAGING.2011.12.023

NSAIDs and enantiomers of flurbiprofen target gamma-secretase and lower Abeta 42 in vivo

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROBIOLAGING.2011.12.023

Rapid appearance and local toxicity of amyloid-beta plaques in a mouse model of Alzheimer's disease

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROBIOLAGING.2011.12.023

Amyloid deposition and inflammation in APPswe/PS1dE9 mouse model of Alzheimer's disease

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROBIOLAGING.2011.12.023

Brain Oligomeric β-Amyloid but Not Total Amyloid Plaque Burden Correlates With Neuronal Loss and Astrocyte Inflammatory Response in Amyloid Precursor Protein/Tau Transgenic Mice

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROBIOLAGING.2011.12.023

Evidence for a role for the group I metabotropic glutamate receptor in the inhibitory effect of tumor necrosis factor-alpha on long-term potentiation

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROBIOLAGING.2011.12.023

Visuo-spatial learning and memory deficits on the Barnes maze in the 16-month-old APPswe/PS1dE9 mouse model of Alzheimer's disease

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROBIOLAGING.2011.12.023

Transplanted astrocytes internalize deposited beta-amyloid peptides in a transgenic mouse model of Alzheimer's disease.

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROBIOLAGING.2011.12.023

Inflammatory changes parallel the early stages of Alzheimer disease

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROBIOLAGING.2011.12.023

The role of an astrocytic NADPH oxidase in the neurotoxicity of amyloid beta peptides

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROBIOLAGING.2011.12.023

Neuro-inflammation induced by lipopolysaccharide causes cognitive impairment through enhancement of beta-amyloid generation

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROBIOLAGING.2011.12.023

TNFalpha plus IFNgamma induce the production of Alzheimer beta-amyloid peptides and decrease the secretion of APPs

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROBIOLAGING.2011.12.023

A randomized, double-blind, study of rofecoxib in patients with mild cognitive impairment

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROBIOLAGING.2011.12.023

Inflammation occurs early during the Abeta deposition process in TgCRND8 mice

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROBIOLAGING.2011.12.023

Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease: a review of 17 epidemiologic studies

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROBIOLAGING.2011.12.023

Inhibitory effect of a tyrosine-fructose Maillard reaction product, 2,4-bis(p-hydroxyphenyl)-2-butenal on amyloid-β generation and inflammatory reactions via inhibition of NF-κB and STAT3 activation in cultured astrocytes and microglial BV-2 cells

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROBIOLAGING.2011.12.023

An update on the efficacy of non-steroidal anti-inflammatory drugs in Alzheimer's disease

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROBIOLAGING.2011.12.023

Inflammatory changes are tightly associated with neurodegeneration in the brain and spinal cord of the APP/PS1KI mouse model of Alzheimer's disease

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROBIOLAGING.2011.12.023

Ibuprofen suppresses plaque pathology and inflammation in a mouse model for Alzheimer's disease.

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROBIOLAGING.2011.12.023

Beta-amyloid deposition and Alzheimer's type changes induced by Borrelia spirochetes.

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROBIOLAGING.2011.12.023

Nonsteroidal anti-inflammatory drugs for the prevention of Alzheimer's disease: a systematic review

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROBIOLAGING.2011.12.023

Early induction of interleukin-6 mRNA in the hippocampus and cortex of APPsw transgenic mice Tg2576.

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROBIOLAGING.2011.12.023

Randomized pilot study of nimesulide treatment in Alzheimer's disease

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROBIOLAGING.2011.12.023

The microglial phagocytic role with specific plaque types in the Alzheimer disease brain

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROBIOLAGING.2011.12.023

Clinical trial of indomethacin in Alzheimer's disease.

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROBIOLAGING.2011.12.023

Enhancement of beta-amyloid precursor protein transcription and expression by the soluble interleukin-6 receptor/interleukin-6 complex.

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROBIOLAGING.2011.12.023

Reciprocal control of inflammatory cytokines, IL-1 and IL-6, and β-amyloid production in cultures

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROBIOLAGING.2011.12.023

The inhibition of long-term potentiation in the rat dentate gyrus by pro-inflammatory cytokines is attenuated in the presence of nicotine

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROBIOLAGING.2011.12.023

Early-stage inflammation and experimental therapy in transgenic models of the Alzheimer-like amyloid pathology

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROBIOLAGING.2011.12.023

Glial reactions and the clearance of amyloid beta protein in the brains of patients with hereditary cerebral hemorrhage with amyloidosis-Dutch type

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROBIOLAGING.2011.12.023

Lipopolysaccharide-induced inflammation exacerbates tau pathology by a cyclin-dependent kinase 5-mediated pathway in a transgenic model of Alzheimer's disease.

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROBIOLAGING.2011.12.023

Inflammation in Alzheimer disease: driving force, bystander or beneficial response?

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROBIOLAGING.2011.12.023

Effects of rofecoxib or naproxen vs placebo on Alzheimer disease progression: a randomized controlled trial

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROBIOLAGING.2011.12.023

Pilot tolerability studies of hydroxychloroquine and colchicine in Alzheimer disease

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROBIOLAGING.2011.12.023

A randomized controlled trial of prednisone in Alzheimer's disease. Alzheimer's Disease Cooperative Study.

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROBIOLAGING.2011.12.023

Neuroinflammation-induced acceleration of amyloid deposition in the APPV717F transgenic mouse

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROBIOLAGING.2011.12.023

Microglial MAC1 receptor and PI3K are essential in mediating β-amyloid peptide-induced microglial activation and subsequent neurotoxicity

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROBIOLAGING.2011.12.023

Assessing the contribution of inflammation in models of Alzheimer's disease

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROBIOLAGING.2011.12.023

miR-106b aberrantly expressed in a double transgenic mouse model for Alzheimer's disease targets TGF-β type II receptor

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROBIOLAGING.2011.12.023

Does a Pro-Inflammatory Process Precede Alzheimers Disease and Mild Cognitive Impairment?

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROBIOLAGING.2011.12.023

Up-regulation of the inflammatory cytokines IFN-gamma and IL-12 and down-regulation of IL-4 in cerebral cortex regions of APP(SWE) transgenic mice

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROBIOLAGING.2011.12.023

Aβ Internalization by Neurons and Glia

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROBIOLAGING.2011.12.023

Contribution of inflammatory processes to Alzheimer's disease: molecular mechanisms

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROBIOLAGING.2011.12.023

Nonsteroidal anti-inflammatory drugs repress beta-secretase gene promoter activity by the activation of PPARgamma

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROBIOLAGING.2011.12.023

Microglia enhance beta-amyloid peptide-induced toxicity in cortical and mesencephalic neurons by producing reactive oxygen species.

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1016/J.NEUROBIOLAGING.2011.12.023

Identifiers

DOI

10.1016/J.NEUROBIOLAGING.2011.12.023

1 reference

14 February 2018

1 reference

14 February 2018